These three types can be separated by the biomarkers of myCAF, which exhibits the high expression of ACTA2, FAP, and TGF-β, and low expression of IL6, which requires direct interaction with cancer cells in PDAC and might be associated with tumor progression. Here, IL6 is linked to cancer.